Our next milestone is to raise $250,000 for a preclinical pig study that will inform a clinical canine glioma study; the next stop is a Phase I in patients.

DNKO thrives on resonant collaboration and transparency. Please don't hesitate to contact us regarding any form of inquiry: 

Kate@DNKO.net Co-Founder & CEO

David@DNKO.net Co-Founder & CSO

We're particularly interested in collaborating with people who have interest and/or expertise in: 

• Fundraising/Philanthropy

• Marketing & Communications

• Clinical collaborators using LITT 

• Preclinical and clinical research for brain cancers and other cancers in general